Results

Anavex Life Sciences Corp.

04/12/2021 | Press release | Distributed by Public on 04/12/2021 05:09

Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials of ANAVEX®2-73 in Patients with Rett Syndrome